Sernova Aktie - SVA

Professionelle Tools für Privatanleger.

Premium

Current Price

0,23

Gebot

0,225

Fragen

0,23

Volumen

9.756

0,225 Tagesbereich 0,23

0,20 52-Wochen-Bereich 0,73

Marktkapitalisierung

69,767M

Handelsende

0,23

Handelsbeginn

0,225

Letzte Trade

2000

0.23

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

103.289

Ausgegebene Aktien

303.333.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,79

Gewinn pro Aktie (EPS)

-0,13

Erlöse

Nettogewinn

-39M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.sernova.com

Hauptsitz

Vancouver, British Columbia, Can

Gegründet

Sernova Corp is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker SVA. The last closing price for Sernova was $0,23. Over the last year, Sernova shares have traded in a share price range of $ 0,20 to $ 0,73.

Sernova currently has 303.333.000 shares in issue. The market capitalisation of Sernova is $69,77 million. Sernova has a price to earnings ratio (PE ratio) of -1.79.

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell...

Sernova Update on Strategic Initiatives

Signed Letter of Intent with ‘Project REEM Ventures’ for Product Development and Commercialization in the Kingdom of Saudi Arabia Renowned Diabetes Expert Dr. Robert Gabbay to Serve as Clinical...

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet transplantationHistological data confirmation of healthy...

Sernova Corp. Announces Appointment of New Chief Executive Officer

LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology...

Sinovac Completes Acquisition Aimed at Expanding Production Capacity

BEIJING, Feb. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced the completion by its subsidiary, Sinovac Beijing, of the...

Sinovac Announces Exercise of Over-Allotment Option

BEIJING, Feb. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that the underwriters of its...

Sinovac Announces Plan to Launch Offering of Common Shares

BEIJING, Jan. 20 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced that it plans to sell, subject to market and other...

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease

BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China's...

Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television

BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that Weidong Yin, Chairman, President & CEO...

Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009

BEIJING, Dec. 21 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac was selected by China Business...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.23	0.235	0.22	132911	0.22897615	CS
4	-0.005	-2.12765957447	0.235	0.26	0.215	112054	0.23155507	CS
12	-0.01	-4.16666666667	0.24	0.275	0.215	103289	0.24342842	CS
26	-0.12	-34.2857142857	0.35	0.39	0.2	165516	0.25582845	CS
52	-0.45	-66.1764705882	0.68	0.73	0.2	160369	0.37255968	CS
156	-1.32	-85.1612903226	1.55	1.59	0.2	131211	0.67640073	CS
260	-1.32	-85.1612903226	1.55	1.59	0.2	131211	0.67640073	CS

SVA - Frequently Asked Questions (FAQ)

What is the current Sernova share price?

The current share price of Sernova is $ 0,23

How many Sernova shares are in issue?

Sernova has 303.333.000 shares in issue

What is the market cap of Sernova?

The market capitalisation of Sernova is CAD 69,77M

What is the 1 year trading range for Sernova share price?

Sernova has traded in the range of $ 0,20 to $ 0,73 during the past year

What is the PE ratio of Sernova?

The price to earnings ratio of Sernova is -1,79

What is the reporting currency for Sernova?

Sernova reports financial results in CAD

What is the latest annual profit for Sernova?

The latest annual profit of Sernova is CAD -39M

What is the registered address of Sernova?

The registered address for Sernova is SUITE 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 2N7

What is the Sernova website address?

The website address for Sernova is www.sernova.com

Which industry sector does Sernova operate in?

Sernova operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
APSAptose Biosciences Inc	$ 0,42 (75,00%)	30,28k
RTGRTG Mining Inc	$ 0,04 (60,00%)	3k
BNGBengal Energy Ltd	$ 0,015 (50,00%)	1.000
BBBlackBerry Limited	$ 5,29 (23,60%)	13,59M
ARAAclara Resources Inc	$ 0,495 (17,86%)	27,19k
BABYElse Nutrition Holdings Inc	$ 0,01 (-33,33%)	190k
DIAMStar Diamond Corporation	$ 0,015 (-25,00%)	2,34M
KRNKarnalyte Resources Inc	$ 0,085 (-19,05%)	20,5k
STEPSTEP Energy Services Ltd	$ 4,18 (-14,87%)	283,69k
SBISerabi Gold Plc	$ 2,13 (-11,62%)	73,81k
CNQCanadian Natural Resources Ltd	$ 42,49 (0,02%)	18,71M
TRPTC Energy Corporation	$ 65,77 (0,84%)	17,86M
CMCanadian Imperial Bank of Commerce	$ 92,48 (0,75%)	16,28M
MFCManulife Financial Corporation	$ 43,54 (0,48%)	14,47M
BBBlackBerry Limited	$ 5,29 (23,60%)	13,59M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Corp (SVA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Sernova Corp

SVA Neueste Nachrichten

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

Sernova Update on Strategic Initiatives

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Sernova Corp. Announces Appointment of New Chief Executive Officer

Sinovac Completes Acquisition Aimed at Expanding Production Capacity

Sinovac Announces Exercise of Over-Allotment Option

Sinovac Announces Plan to Launch Offering of Common Shares

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease

Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television

Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

Sernova Update on Strategic Initiatives

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Sernova Corp. Announces Appointment of New Chief Executive Officer

SVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Corp (SVA) Börsenkurse

Sernova Corp (SVA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Sernova Corp

SVA Neueste Nachrichten

SVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen